Glucose Control and ICH Risk

Dr. Stacey Clardy talks with Dr. John Ney about the prevalence, disability burden, and societal impact of neurologic disorders in the U.S. Read the related article in JAMA. Disclosures can be found at Neurology.org. 

In the second episode of this two-part series, Dr. Justin Abbatemarco talks with Drs. Valérie Biousse and Nancy J. Newman about the management of non-arteritic ischemic optic neuropathy and its emerging relationship with GLP‑1 medications. Disclosures can be found at Neurology.or ...  Show more

Drs. Justin Abbatemarco and Géraldine Androdias discuss the impact of immune checkpoint inhibitors on the course of multiple sclerosis.  Show reference:  https://www.neurology.org/doi/10.1212/NXI.0000000000200202   This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for ...  Show more

Dr. Derek Stitt and Dr. Adam de Havenon discuss the burden of neurologic health care and incident neurologic diagnoses in the year after COVID-19 vs influenza.  Show reference: https://doi.org/10.1212/wnl.0000000000209248   This podcast is sponsored by argenx. Visit www.vyvgarthcp ...  Show more

Dr. Mahinda Yogarajah discusses the importance of diagnosing and not misdiagnosing functional neurologic disorders. Show references: https://n.neurology.org/content/early/2023/06/20/WNL.0000000000207388 This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more inform ...  Show more

This podcast presents an approach to management of diabetic ketoacidosis in children. In this episode, listeners will learn signs and symptoms, diagnostic criteria, and the differential diagnosis for triggers of diabetic ketoacidosis. This podcast was created by Dr. Carly Rumley ...  Show more